Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Survival Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Surveys and Questionnaires < Survival Analysis < Survival Rate  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000169 (2021) Khalid Changal ; David Paternite ; Sean Mack ; Spiro Veria ; Rehana Bashir ; Mitra Patel ; Ronak Soni ; Muhammad Ali ; Tanveer Mir ; Mujeeb Sheikh ; P Kasi RamanathanCoronavirus disease 2019 (COVID-19) and QTc prolongation.
000335 (2021) Nirvana Awad ; Daryl S. Schiller ; Magda Fulman ; Azfar ChakImpact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection.
000531 (2021) Philippe Gautret ; Van Thuan Hoang ; Jean-Christophe Lagier ; Didier RaoultEffect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000742 (2021) Nicolas De Schryver ; Nicolas Serck ; Marco Vinetti ; Ludovic GérardLow-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
000A17 (2021) Michael Ewers ; John P A. Ioannidis ; Nikolaus PlesnilaAccess to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
000A36 (2020) Sarah Micallef ; Tonio V. Piscopo ; Ramon Casha ; Denise Borg ; Chantal Vella ; Maria-Alessandra Zammit ; Janice Borg ; Daniela Mallia ; James Farrugia ; Sarah Marie Vella ; Thelma Xerri ; Anette Portelli ; Manuel Fenech ; Claudia Fsadni ; Charles Mallia AzzopardiThe first wave of COVID-19 in Malta; a national cross-sectional study.
000B54 (2021) Michele Bartoletti ; Lorenzo Marconi ; Luigia Scudeller ; Livia Pancaldi ; Sara Tedeschi ; Maddalena Giannella ; Matteo Rinaldi ; Linda Bussini ; Ilaria Valentini ; Anna Filomena Ferravante ; Antonella Potalivo ; Elisa Marchionni ; Giacomo Fornaro ; Renato Pascale ; Zeno Pasquini ; Massimo Puoti ; Marco Merli ; Francesco Barchiesi ; Francesca Volpato ; Arianna Rubin ; Annalisa Saracino ; Tommaso Tonetti ; Paolo Gaibani ; Vito Marco Ranieri ; Pierluigi Viale ; Francesco CristiniEfficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
000D53 (2021) Thibault Fiolet ; Anthony Guihur ; Mathieu Edouard Rebeaud ; Matthieu Mulot ; Nathan Peiffer-Smadja ; Yahya Mahamat-SalehEffect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
000D70 (2020) Ehsan Sekhavati ; Fatemeh Jafari ; Seyedahmad Seyedalinaghi ; Saeidreza Jamalimoghadamsiahkali ; Sara Sadr ; Mohammad Tabarestani ; Mohammad Pirhayati ; Abolfazl Zendehdel ; Navid Manafi ; Mahboubeh Hajiabdolbaghi ; Zahra Ahmadinejad ; Hamid Emadi Kouchak ; Sirous Jafari ; Hosein Khalili ; Mohamadreza Salehi ; Arash Seifi ; Fereshteh Shahmari Golestan ; Fereshteh GhiasvandSafety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
000E40 (2020) Sherief Abd-Elsalam ; Eslam Saber Esmail ; Mai Khalaf ; Ehab Fawzy Abdo ; Mohammed A. Medhat ; Mohamed Samir Abd El Ghafar ; Ossama Ashraf Ahmed ; Shaimaa Soliman ; Ghada N. Serangawy ; Mohamed AlboraieHydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
000E64 (2020) Shubham Misra ; Manabesh Nath ; Vijay Hadda ; Deepti VibhaEfficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
000F76 (2020) Benjamin Davido ; Ghilas Boussaid ; Isabelle Vaugier ; Thibaud Lansaman ; Frédérique Bouchand ; Christine Lawrence ; Jean-Claude Alvarez ; Pierre Moine ; Véronique Perronne ; Frédéric Barbot ; Azzam Saleh-Mghir ; Christian Perronne ; Djillali Annane ; Pierre De TruchisImpact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
001060 (2020) Lorenzo M. Canziani ; Serena Trovati ; Enrico Brunetta ; Amidio Testa ; Maria De Santis ; Emilio Bombardieri ; Giacomo Guidelli ; Giovanni Albano ; Marco Folci ; Michela Squadroni ; Giordano D. Beretta ; Michele Ciccarelli ; Massimo Castoldi ; Ana Lleo ; Alessio Aghemo ; Laura Vernile ; Alberto Malesci ; Paolo Omodei ; Claudio Angelini ; Salvatore Badalamenti ; Maurizio Cecconi ; Alberto Cremonesi ; Carlo SelmiInterleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
001093 (2020) Mohammad Sultan KhurooChloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
001144 (2021) Viveksandeep Thoguluva Chandrasekar ; Bhanuprasad Venkatesalu ; Harsh K. Patel ; Marco Spadaccini ; Jacob Manteuffel ; Mayur RameshSystematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
001158 (2020) Effat Davoudi-Monfared ; Hamid Rahmani ; Hossein Khalili ; Mahboubeh Hajiabdolbaghi ; Mohamadreza Salehi ; Ladan Abbasian ; Hossein Kazemzadeh ; Mir Saeed YekaninejadA Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.
001200 (2020) Catia Marzolini ; Felix Stader ; Marcel Stoeckle ; Fabian Franzeck ; Adrian Egli ; Stefano Bassetti ; Alexa Hollinger ; Michael Osthoff ; Maja Weisser ; Caroline E. Gebhard ; Veronika Baettig ; Julia Geenen ; Nina Khanna ; Sarah Tschudin-Sutter ; Daniel Mueller ; Hans H. Hirsch ; Manuel Battegay ; Parham SendiEffect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
001216 (2020) Miguel Angel MartinezClinical Trials of Repurposed Antivirals for SARS-CoV-2.
001290 (2020) Chang Li ; Lin Wang ; Linzhu RenAntiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
001320 (2020) Anne Lohse ; Timothée Klopfenstein ; Jean-Charles Balblanc ; Pierre-Yves Royer ; Marie Bossert ; Vincent Gendrin ; Aline Charpentier ; Ana-Maria Bozgan ; Julio Badie ; Charlotte Bourgoin ; Remy Contreras ; Isabelle Mazurier ; Thierry Conrozier ; Souheil ZayetPredictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
001334 (2020) Ana Fernández-Cruz ; Belén Ruiz-Antorán ; Ana Mu Oz-G Mez ; Aránzazu Sancho-L Pez ; Patricia Mills-Sánchez ; Gustavo Adolfo Centeno-Soto ; Silvia Blanco-Alonso ; Laura Javaloyes-Garachana ; Amy Galán-G Mez ; Ángela Valencia-Alijo ; Javier G Mez-Irusta ; Concepci N Payares-Herrera ; Ignacio Morrás-Torre ; Enrique Sánchez-Chica ; Laura Delgado-Téllez-De-Cepeda ; Alejandro Callejas-Díaz ; Antonio Ramos-Martínez ; Elena Mú Ez-Rubio ; Cristina Avenda O-SoláA Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Survival Analysis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Survival Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Survival Analysis
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021